CardioVascular Dynamics (CVD) gets clearance for coronary catheter:
This article was originally published in Clinica
EndoSonics' subsidiary CardioVascular Dynamics (US) has been granted FDA clearance to market its Active Response Catheter coronary balloon. CVD intends to begin shipment of the catheters in the US towards the end of 1996.
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.